Last 47 quarters of trend data · Healthcare · Biotechnology
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
XOMA Royalty Corp.'s quarterly P/E stands at 13.8x.
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -16.03 | 13.76 | 14.32 | 73.49 | — | — | 4.74 | — | — | — | — | — | — |
| — | — | +202.2% | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 11.10 | 18.69 | 8.52 | 4.61 | 8.93 | 10.77 | 12.20 | 46.73 | 28.96 | 48.69 | 32.66 | 138.40 | 35.45 |
| — | +73.5% | -30.1% | -90.1% | -69.1% | -77.9% | -62.6% | -66.2% | -18.3% | -57.2% | -49.5% | +442.6% | +1923.9% | |
| P/B Ratio | 3.78 | 6.48 | 4.84 | 3.47 | 3.80 | 3.66 | 2.76 | 3.38 | 2.39 | 1.53 | 1.97 | 2.11 | 1.70 |
| — | +77.1% | +75.5% | +2.6% | +58.8% | +139.7% | +40.3% | +60.1% | +40.8% | -3.0% | +4.3% | -6.8% | -4.3% | |
| P/FCF | — | — | 17.51 | 33.39 | — | — | 25.29 | — | — | — | — | — | — |
| — | — | -30.8% | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | — | 10.64 | 23.15 | 12.27 | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | 10.64 | 9.80 | 13.62 | — | — | 3.27 | — | — | — | — | — | — |
| — | — | +199.3% | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
XOMA Royalty Corp.'s operating margin was -14.2% in Q3 2025, down 49.3 pp QoQ and up 203.1 pp YoY. This marks the 3rd consecutive quarter of margin compression, signaling a persistent pressure on profitability that investors should monitor. The trailing four-quarter average of -6.3% exceeds the current quarter, suggesting the latest result may reflect seasonal weakness or a one-off headwind. Gross margin contracted 9.4% YoY, suggesting cost inflation or competitive pricing pressure.
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 99.3% | 90.6% | 95.0% | 96.6% | 90.1% | 100.0% | 100.0% | 99.9% | 98.6% | 97.0% | 97.6% | 87.6% | 98.1% |
| — | -9.4% | -5.0% | -3.3% | -8.7% | +3.1% | +2.4% | +13.9% | +0.5% | +3.7% | +1.8% | -10.7% | -1.8% | |
| Operating Margin | -140.3% | -14.2% | 35.1% | 37.3% | -83.2% | -217.3% | -178.3% | -470.1% | -1087.5% | -697.2% | -359.3% | -2327.2% | -417.9% |
| — | +93.5% | +119.7% | +107.9% | +92.3% | +68.8% | +50.4% | +79.8% | -160.2% | +28.1% | +25.9% | -3401.6% | -594.7% | |
| Net Margin | -48.5% | 150.3% | 52.5% | 14.9% | -45.5% | -239.6% | 282.7% | -576.8% | -1097.1% | -663.7% | -325.7% | -2245.5% | -402.2% |
| — | +162.7% | -81.4% | +102.6% | +95.8% | +63.9% | +186.8% | +74.3% | -172.8% | +28.4% | +31.4% | -2960.0% | -584.4% |
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -16.2% | 14.0% | 7.8% | 2.8% | -4.8% | -18.7% | 17.5% | -10.0% | -20.7% | -5.1% | -4.8% | -8.2% | -4.7% |
| — | +175.1% | -55.6% | +128.3% | +77.0% | -266.0% | +464.7% | -22.1% | -339.6% | -61.9% | -41.5% | -408.4% | -120.0% | |
| ROA | -6.1% | 5.8% | 3.2% | 1.1% | -1.8% | -7.4% | 6.9% | -3.8% | -11.2% | -4.4% | -4.2% | -7.2% | -4.2% |
| — | +178.1% | -54.3% | +128.8% | +84.1% | -67.5% | +265.9% | +47.1% | -169.0% | -58.6% | -39.7% | -411.5% | -120.8% | |
| ROIC | -37.6% | -0.7% | 2.9% | 4.3% | -6.8% | -16.8% | -10.4% | -8.3% | -22.6% | -5.7% | -6.0% | -11.2% | -7.9% |
| — | +95.8% | +127.5% | +151.6% | +70.1% | -192.5% | -73.8% | +25.9% | -187.0% | +8.9% | +12.6% | -264.7% | -115.9% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
XOMA Royalty Corp.'s Debt/EBITDA ratio is 7.6x, down from 21.8x last quarter — elevated, raising questions about debt serviceability. The current ratio has weakened 48.0% YoY to 3.91x, tightening the short-term liquidity position. Debt/Equity has declined for 4 consecutive quarters, reflecting a deleveraging trend.
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 1.46 | 1.22 | 1.24 | 1.35 | 1.46 | 1.40 | 1.22 | 1.47 | 1.40 | — | 0.00 | 0.00 | 0.00 |
| — | -12.9% | +1.6% | -8.0% | +3.7% | — | +791669.5% | +244095.5% | +511838.7% | — | -84.4% | -53.7% | -83.0% | |
| Debt / EBITDA | — | 7.58 | 21.78 | 17.67 | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 5.15 | 3.91 | 4.88 | 5.54 | 5.15 | 7.52 | 8.71 | 9.45 | 8.68 | 3.34 | 5.42 | 4.47 | 8.98 |
| — | -48.0% | -44.0% | -41.4% | -40.7% | +125.4% | +60.7% | +111.7% | -3.3% | -77.3% | -47.7% | -60.7% | +20.1% | |
| Quick Ratio | 5.15 | 3.91 | 4.88 | 5.54 | 5.15 | 7.64 | 8.71 | 9.45 | 8.68 | 3.34 | 5.42 | 4.47 | 8.98 |
| — | -48.8% | -44.0% | -41.4% | -40.7% | +128.7% | +60.7% | +111.7% | -3.3% | -77.3% | -47.7% | -60.7% | +20.1% | |
| Interest Coverage | -2.89 | -0.40 | 1.42 | 1.71 | -2.14 | -4.48 | -2.96 | -1.97 | -35.03 | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 47 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare performance and metrics against top competitors.
Start ComparisonXOMA Royalty Corp.'s current P/E is -16.0x. The average P/E over the last 3 quarters is 33.9x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
XOMA Royalty Corp.'s current operating margin is -140.3%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking XOMA Royalty Corp.'s business trajectory between earnings reports.